Charles Khouri

2.3k total citations
84 papers, 1.0k citations indexed

About

Charles Khouri is a scholar working on Pulmonary and Respiratory Medicine, Toxicology and Pharmacology. According to data from OpenAlex, Charles Khouri has authored 84 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Toxicology and 11 papers in Pharmacology. Recurrent topics in Charles Khouri's work include Pharmacovigilance and Adverse Drug Reactions (18 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Systemic Sclerosis and Related Diseases (9 papers). Charles Khouri is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (18 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Systemic Sclerosis and Related Diseases (9 papers). Charles Khouri collaborates with scholars based in France, Italy and United States. Charles Khouri's co-authors include Jean‐Luc Cracowski, Matthieu Roustit, Bruno Revol, Marion Lepelley, S. Blaise, P. Carpentier, Marc Humbert, Jean‐Louis Pépin, Jeremy K. Ward and Francesco Salvo and has published in prestigious journals such as Circulation, Nature Medicine and Annals of Internal Medicine.

In The Last Decade

Charles Khouri

75 papers receiving 1.0k citations

Peers

Countries citing papers authored by Charles Khouri

Since Specialization

Citations

This map shows the geographic impact of Charles Khouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Khouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Khouri more than expected).

Fields of papers citing papers by Charles Khouri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Khouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Khouri. The network helps show where Charles Khouri may publish in the future.

Co-authorship network of co-authors of Charles Khouri

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Khouri. A scholar is included among the top collaborators of Charles Khouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Khouri. Charles Khouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension 2026 ·Circulation ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sandra Martineau, (unknown), (unknown), Grégoire Ruffenach, (unknown), Malik Bisserier, Steeve Provencher, Sébastien Bonnet, (unknown), Charles Khouri, (unknown)	0
2	Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database 2025 ·Arthritis & Rheumatology ·(unknown), (unknown), Jean‐Luc Cracowski, Matthieu Roustit, Charles Khouri	0
3	Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats 2025 ·ERJ Open Research ·(unknown), (unknown), Laurent Savale, Jason Weatherald, (unknown), (unknown), Marie‐Camille Chaumais, Marc Humbert, Charles Khouri, David Montani	0
4	The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline 2024 ·Frontiers in Pharmacology ·Michele Fusaroli, Francesco Salvo, Charles Khouri, Emanuel Raschi	7
5	Association of Pulmonary Hypertension With Trastuzumab Emtansine 2024 ·CHEST Journal ·(unknown), (unknown), Nicolas Favrolt, Marie‐Camille Chaumais, (unknown), Étienne-Marie Jutant, Benoît Lechartier, (unknown), (unknown), S. Palat, (unknown), Fabrice Antigny, Vincent Cottin, Guillaume Beltramo, Marc Humbert, Charles Khouri, Philippe Bonniaud, David Montani	2
6	Cerebral oxidative stress, inflammation and apoptosis induced by intermittent hypoxia: a systematic review and meta-analysis of rodent data 2024 ·European Respiratory Review ·(unknown), (unknown), (unknown), Sébastien Baillieul, Frédéric Roche, Nathalie Perek, Jean‐Louis Pépin, Renaud Tamisier, Charles Khouri, Claire Rome, Anne Briançon‐Marjollet	6
7	Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports 2024 ·Journal of Clinical Psychopharmacology ·Michele Fusaroli, Charles Khouri, Elisabetta Poluzzi, Fabrizio De Ponti, Francesco Salvo, Emanuel Raschi	2
8	Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors 2024 ·European Respiratory Journal ·(unknown), Charles Khouri, (unknown), Xavier Jaïs, Laurent Savale, Marie‐Camille Chaumais, (unknown), Mitja Jevnikar, Athénaïs Boucly, Fabrice Antigny, Frédéric Perros, Gérald Simonneau, Olivier Sitbon, Marc Humbert, David Montani	7
9	Priors and decision thresholds in phase 2 and phase 3 randomized controlled trials evaluating drug efficacy using Bayesian methods: a systematic review 2024 ·Journal of Clinical Epidemiology ·(unknown), (unknown), (unknown), Joris Giai, Silvy Laporte, Édouard Ollier, Nicolás Meyer, Charles Khouri, Michel Cucherat, Matthieu Roustit	1
10	Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data 2023 ·Archivos de Bronconeumología ·Mathieu Delorme, (unknown), Marius Lebret, (unknown), Anda Hazenberg, Mercedes Pallero, Annabel H. Nickol, Liam M. Hannan, Matthias Boentert, (unknown), Wolfram Windisch, Mark E. Howard, Nicholas Hart, Peter J. Wijkstra, Hélène Prigent, Jean‐Louis Pépin, Frédéric Lofaso, Charles Khouri, Jean‐Christian Borel	5
11	Co-authorship group significantly impacts reported arterial blood pressure variations in rodents exposed to intermittent hypoxia: a meta-research study 2023 ·Cardiovascular Research ·Charles Khouri, (unknown), Claire Arnaud, Elise Belaïdi, (unknown), Diane Godin‐Ribuot, Patrick Lévy, Gilles Faury, (unknown), Jean‐Luc Cracowski, Anne Briançon‐Marjollet, Jean‐Louis Pépin	4
12	Investigating the link between drug consumption and adverse events reporting in France 2023 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), (unknown), Jean‐Luc Cracowski, Charles Khouri	3
13	Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data 2022 ·Clinical Drug Investigation ·(unknown), Marine Auffret, Antoine Pégat, Kamel Masmoudi, Charles Khouri, (unknown), Thierry Vial	14
14	Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents 2022 ·European Respiratory Review ·Elise Belaïdi, Charles Khouri, (unknown), Sébastien Baillieul, Gilles Faury, Anne Briançon‐Marjollet, Jean‐Louis Pépin, Claire Arnaud	25
15	Placebo response in Raynaud's Phenomenon clinical trials: The prominent role of regression towards the mean 2022 ·Seminars in Arthritis and Rheumatism ·Matthieu Roustit, (unknown), (unknown), (unknown), S. Blaise, Jean‐Luc Cracowski, Charles Khouri	4
16	Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis 2022 ·PLoS ONE ·(unknown), Charles Khouri, Stéphanie Marlière, (unknown), (unknown), Olivier Ormezzano, Bernard Bertrand, Hélène Bouvaist, Laurent Riou, Loïc Djaileb, (unknown), Gérald Vanzetto, Matthieu Roustit, Gilles Barone‐Rochette	13
17	Sleep disturbances in early clinical stages of psychotic and bipolar disorders: A meta-analysis 2021 ·Australian & New Zealand Journal of Psychiatry ·Clément Dondé, (unknown), Charles Khouri, (unknown), Renaud Tamisier, Michel Lejoyeux, Marie‐Pia d’Ortho, Mircea Polosan, Pierre A. Geoffroy	7
18	Gout and Levodopa: An unknown adverse effect? 2021 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), Athan Baillet, Elena Moro, Benoît Allenet, Charles Khouri	0
19	Intermittent hypoxia-related alterations in vascular structure and function: a systematic review and meta-analysis of rodent data 2021 ·European Respiratory Journal ·(unknown), (unknown), Jean‐Louis Pépin, Claire Arnaud, Elise Belaïdi, Gilles Faury, Charles Khouri, Anne Briançon‐Marjollet	30
20	Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials 2019 ·The Lancet Rheumatology ·Charles Khouri, Marion Lepelley, Sébastien Bailly, S. Blaise, Ariane L. Herrick, Marco Matucci‐Cerinic, Yannick Allanore, Ludovic Trinquart, Claire Cracowski, Matthieu Roustit	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact